The treatment of epilepsy is complicated and often fails to achieve the one main goal of treatment – the elimination of seizures. Far too often patients are treated with multiple drugs that lead to serious adverse events or drug-drug interactions and still have seizures that impair their ability to function. There is an ever-present need for newer, more effective agents with fewer side effects and less complicated drug-drug interactions. Clearly, there is a significant place for pharmacists in assuring appropriate treatment and monitoring is provided for epilepsy patients.

Since 2009, five, new antiepileptic (AEDs) have been approved by the US